Niagen Bioscience Inc (NASDAQ:NAGE) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to Niagen Bioscience Inc First Quarter 2026 Earnings Conference Call.
Niagen Bioscience Inc. (NAGE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 2,378,437 | $10,488,907 | +48% | 0.01% |
| 2. | Renaissance Technologies Jim Simons | 1,328,843 | $5,860,198 | +46% | 0.01% |
| 3. | AQR Capital Management Cliff Asness | 1,031,335 | $4,548,187 | +71% | 0% |
| 4. | Trexquant Investment LP Tyger (Taesoon) Park | 576,816 | $2,543,759 | +33% | 0.02% |
| 5. | Millennium Management Israel Englander | 551,349 | $2,431,449 | -2% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.85 | 2,220 | $15,210.03 | 2,220 | 2025-11-14 | Filing | |
| $6.81 | 4,465 | $30,406.39 | 7,372 | 2025-11-14 | Filing | |
| $7.86 | 273 | $2,145.78 | 2,251 | 2025-03-07 | Filing | |
| $7.36 | 2,907 | $21,396.97 | 2,907 | 2024-11-22 | Filing | |
| $0.00 | 11,408,715 | $0.00 | 19,294,356 | 2024-08-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.19 | 37,161 | $229,955.98 | 244,179 | 2024-12-13 | Filing | |
| $3.57 | 23,000 | $82,110.00 | 0 | 2024-08-23 | Filing | |
| $0.00 | 11,408,715 | $0.00 | 0 | 2024-08-20 | Filing | |
| $13.17 | 20,000 | $263,400.00 | 16,667 | 2021-03-16 | Filing | |
| $11.15 | 32,500 | $362,375.00 | 16,667 | 2021-03-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,871,619 | $17,073,839 | 0% | |
| 2. | 3,373,000 | $14,874,930 | 0.45% | |
| 3. | 2,149,277 | $9,478,312 | 0% | |
| 4. | 1,714,639 | $7,561,558 | 0.01% | |
| 5. | 1,405,531 | $6,198,392 | 0% |
News See All
10 Best Consumer Staples Penny Stocks to Buy Now
On April 10, CNBC reported that consumer sentiment plunged to its lowest level in April, fueled by concerns about high inflation amid the ongoing conflict in the Middle East.
12 Cheap Penny Stocks to Invest In Now
As macroeconomic uncertainty builds in 2026, investors are increasingly re-evaluating where to find resilient and opportunistic returns.
Canaccord Lowers Niagen Bioscience, Inc. (NAGE) PT on Updated Forecasts Following Q4 Results
TheFly reported on March 5 that Canaccord Genuity revised its price target for NAGE to $13, down from $14, while maintaining a Buy rating.
12 Penny Stocks with Insider Buying in 2026
The CEO of Wealth Consulting Group, Jimmy Lee, told BNN Bloomberg on March 25 that as conditions calm, the ongoing geopolitical crises in the Middle East may eventually present investors with selective...
Niagen Bioscience Inc (NASDAQ:NAGE) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to Niagen Bioscience, Inc. Fourth Quarter of 2025 Earnings Conference Call.
Niagen Bioscience, Inc. (NAGE): A Bull Case Theory
We came across a bullish thesis on Niagen Bioscience, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on NAGE.
Niagen Bioscience Inc (NASDAQ:NAGE) Q3 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Niagen Biosciences, Inc. Third Quarter of 2025 Earnings Conference Call.
Niagen Bioscience Inc (NASDAQ:NAGE) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to Niagen Biosciences Inc. First Quarter of 2025 Earnings Conference Call.
Hedge Fund Resource Center